- Home
- PLUR vs FCO Comparison
PLUR vs FCO Comparison
Compare PLUR & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLUR | FCO |
|---|---|---|
| Founded | 2001 | 1991 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.9M | 39.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PLUR | FCO |
|---|---|---|
| Price | $3.04 | $2.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 47.8K | ★ 100.1K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $1,326,000.00 | N/A |
| Revenue This Year | $97.38 | N/A |
| Revenue Next Year | $293.97 | N/A |
| P/E Ratio | ★ N/A | $12.30 |
| Revenue Growth | ★ 121.74 | N/A |
| 52 Week Low | $3.02 | $4.73 |
| 52 Week High | $7.13 | $6.63 |
Technical Indicators
Market Signals| Indicator | PLUR | FCO |
|---|---|---|
| Relative Strength Index (RSI) | 38.75 | 37.87 |
| Support Level | $3.10 | $2.80 |
| Resistance Level | $3.92 | $2.99 |
| Average True Range (ATR) | 0.31 | 0.08 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 7.03 | 41.38 |
Price Performance
Historical ComparisonAbout PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.